Results 131 to 137 of about 321,693 (137)

Is the Injectable Contraceptive Depo-Medroxyprogesterone Acetate (DMPA-IM) Associated with an Increased Risk for HIV Acquisition? The Jury Is Still Out

AIDS Research and Human Retroviruses, 2020
Janet Hapgood
exaly  

Factors affecting continuation rates of DMPA

Contraception, 1999
David Hubacher, Doug Taylor, D Hubacher   +2 more
exaly  

Menstrual pattern changes from levonorgestrel subdermal implants and DMPA: systematic review and evidence-based comparisons

Contraception, 2009
David Hubacher, Markus J Steiner
exaly  

DMPA-SC 104 provides similar duration of posttreatment relief from the symptoms of endometriosis as compared with leuprolide acetate

Contraception, 2005
WD Schlaff, SA Carson
openaire   +1 more source

DMPA-SC 104 has significantly less impact on bone mineral density than leuprolide acetate in patients with endometriosis

Contraception, 2005
DF Archer, JC Gallagher
openaire   +1 more source

The effect of depot medroxyprogesterone acetate (DMPA) on bone mineral density (BMD) and evaluating changes in BMD after discontinuation of DMPA in Chinese women of reproductive age

Contraception, 2011
exaly  

Efficacy of a selective COX-2 inhibitor for controlling irregular uterine bleeding in DMPA users

Contraception, 2006
Surasak Taneepanichskul
exaly